Home Journals Articles Updates About
CN
image
收藏切换
(−)- and (+)-Securidanes A and B, Natural Triarylmethane Enantiomers: Structure and Bioinspired Total Synthesis
收藏切换
PDF
B. Zhou1, D. X. Liu2, X. J. Yuan1, J. Y. Li1, Y. C. Xu1, J. Li1, Y. Li2, J. M. Yue1
Research. Vol 2018 Article ID 2674182
Less
收藏切换
Research. Vol 2018 Article ID 2674182
• Research Article •
(−)- and (+)-Securidanes A and B, Natural Triarylmethane Enantiomers: Structure and Bioinspired Total Synthesis
Full
B. Zhou1, D. X. Liu2, X. J. Yuan1, J. Y. Li1, Y. C. Xu1, J. Li1, Y. Li2, J. M. Yue1
Affiliations
  • 1State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China
  • 2State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China
About Author:

Authors’ Contributions

All authors designed the research. B. Zhou performed compounds isolation and structure identification. D. X. Liu and Y. Li contributed to the synthesis work. J. Y. Li and J. Li finished PTP1B inhibitory assay. X. J. Yuan and Y. C. Xu performed the molecular docking. B. Zhou, D. X. Liu, and X. J. Yuan wrote the manuscript. J. M. Yue supervised the project and provided comments and revisions on the manuscript. B. Zhou and D. X. Liu contributed equally to this work.

Published: 2018-09-20 doi: 10.1155/2018/2674182
Outline
收藏切换

Two pairs of enantiomers, (−) and (+)-securidanes A (1 and 2) and B (3 and 4) featuring unprecedented triarylmethane (TAM) skeletons, were isolated from Securidaca inappendiculata. Their structures were established by spectroscopic data, X-ray crystallography, and CD analysis. A plausible biosynthetic pathway for 1−4 based on the co-isolated precursors was proposed. Bioinspired total synthesis of 1−4 was completed in high yield, which in turn corroborated the biosynthetic hypothesis. Compounds 1−4 showed good inhibition against protein tyrosine phosphatase 1B (PTP1B). The molecular docking demonstrated that the strongest inhibitor 3 (IC50 = 7.52 μM) reaches deeper into the binding pocket and has an additional H-bond.

B. Zhou, D. X. Liu, X. J. Yuan, J. Y. Li, Y. C. Xu, J. Li, Y. Li, J. M. Yue. (−)- and (+)-Securidanes A and B, Natural Triarylmethane Enantiomers: Structure and Bioinspired Total Synthesis[J]. Research, 2018 , 2018 (9) : 2674182 - . DOI: 10.1155/2018/2674182
Full Text
Less
1. 　Introduction
Less
Compounds incorporating the triarylmethane (TAM) motif are well recognized in materials science, such as fluorescent probes, organic dyes, and metal ion sensors [1–5]. It is particularly interesting that TAM derivatives have also demonstrated a broad spectrum of biological significance including anticancer, K+ channel blocking, histidine protein kinase inhibitory, and antiparasitic, antiviral, and antitubercular activities [6–10]. Given the important roles of TAMs in materials science and medicinal chemistry, this compound class has attracted widespread attention in the area of organic chemistry and a number of synthetic methods have been developed by involving the key steps of Friedel−Crafts reaction, transition-metal-catalytic cross-coupling reaction, and reductive dehydroxylation of triarymethanol derivatives, including a few approaches of asymmetric catalysis [11–25], which has led to the synthesis of a large array of TAMs. However, only a very limited number of flavonoid derivatives with a TAM motif have been identified from natural products hitherto [26–29].
The plant Securidaca inappendiculata Hassk. (Polygalaceae) is mainly distributed in the south of China and the tropical regions of Asia. The whole plants have been applied in the remedies of traditional Chinese medicine [30], from which a number of xanthone, benzophenone, and sterol derivatives were identified with anti-inflammatory, anti-HIV, and MAO inhibitory activities [31–34]. In this study, two enantiomeric pairs, (−)- and (+)-securidanes A (1 and 2) and B (3 and 4) featuring new TAM skeletons, were obtained as optically pure compounds by chiral separation from the stems of S. inappendiculata (Figure 1). Compounds 1−4 biosynthetically descended from a diphenylmethane and a diphenyl derivative are unprecedented, and a plausible biosynthetic pathway based on the coisolated precursor 5 was proposed. Bioinspired total synthesis of 1−4 was completed in high yield, which in turn corroborated the biosynthetic hypothesis. PTP1B plays a profound role in cell regulation, growth, and the onset of human diseases. Its overexpression causes persistent dephosphorylation of insulin receptor, stimulating the insulin-resistant phenotype in type 2 diabetes and obesity [35]. PTP1B has thus been considered as a potential therapeutic target for type 2 diabetes and obesity [36, 37]. Compounds 1−4 showed PTP1B inhibitions with IC50 values ranging from 7.5 to 15.6 μm. The molecular docking showed that the strongest inhibitor 3 reaches deeper into the binding pocket and has an additional H-bond. Herein, we present the isolation, chiral separation, structural elucidation, biological evaluation, and bioinspired total synthesis of 1–4.
2. 　Results
Less
(−)-Securidane A (1) was obtained as colorless crystals (in MeOH) with α22D  −76.9 (c 0.42, MeOH). The molecular formula, C28H24O5 with 17 double-bond equivalents (DBEs), was determined by the HRESIMS ion at m/z 441.1700 [M + H]+ (calcd 441.1697) and the NMR data. Its IR absorption bands showed the presence of hydroxy (3487 cm−1) and aromatic (1613 and 1576 cm−1) functionalities. The 1H NMR data (Table S1) displayed the diagnostic resonances of two methoxy and one methylenedioxy groups. The 13C NMR data (Table S1) with the aid of DEPT experiments revealed the existence of two methyls, one methylene, 15 methines (14 sp2 and one sp3), and 10 sp2 quaternary carbons. Comprehensive analysis of 1H and 13C NMR data indicated the presence of four phenyl groups (two mono- and two tetrasubstituted), which accounted for 16 out of the 17 DBEs, and the remaining one DBE required one more ring in the molecule. A singlet proton signal at δH 5.40 that did not show correlations with any carbons in the HSQC spectrum (Figure S12) was assigned to a hydroxy group. Particularly, the diagnostic sp3 methane group (δH 5.58, s; δC 45.0) suggested that it is a TAM derivative.
The planar structure of 1 was established by 2D NMR analysis (Figure S1). Three proton-bearing coupling fragments as drawn in bold bonds were revealed by 1H-1H COSY spectrum. In the HMBC spectrum, the key correlations from H-13 to C-1, C-7, and C-6′ attached three phenyls to C-13. The HMBC correlations of H-12′/C-1′ and H-2′/C-7′ placed the remaining phenyl unit at C-1′ to form a diphenyl motif via the C-1′−C-7′ bond. Two methoxyls were located at C-2 and C-3′ by the HMBCs of 2-OCH3/C-2 and 3′-OCH3/C-3′, respectively. The only hydroxy group was assigned to C-5′ by the key HMBC correlation of 5′-OH/C-5′. The downfield shifted methylene signals (δH 5.93, 5.95; δC 101.2) was assigned to a 3,4-methylenedioxy group by the chemical shifts and the HMBCs from the two protons to both C-3 and C-4. The planar structure of 1 was thus delineated. The absolute configuration of 1 was unambiguously determined as 13R by a single crystal X-ray diffraction study (Figure 2), in which the anomalous dispersion of Cu Kα radiation was applied and the absolute structure parameter of −0.13(7) was acquired.
(+)-Securidane A (2) shared the same molecular formula and identical NMR data with 1 (Table S1, Figures S18 and S19), but had an opposite specific rotation α22D +72.3 (c 0.48, MeOH) and CD curve to that of 1 (Figure 3), indicating that it is the enantiomer of 1 and 13S-configured. Crystallization of 2 from methanol allowed for a successful performance of X-ray diffraction analysis (Figure 4), which not only confirmed its absolute configuration [absolute structure parameter 0.04(10)], but also provided solid evidence to understand the conformation and molecular assembling patterns of enantiomeric pair of triarylmethane-type compounds 1 and 2 in the solid state.
(−)-Securidane B (3), α22D  −43.5 (c 0.37, MeOH), had a molecular formula of C28H24O5 as determined by the HRESIMS ion at m/z 441.1707 [M + H]+ (calcd 441.1697). The NMR data (Table S1) showing great similarities to those of 1 suggested that it is also a TAM analogue. The major differences observed in its 13C NMR spectrum (Table S1) were the C-4′ and C-6′. The quaternary C-4′ (δC 116.7) and the methine C-6′(δC 102.4) resonated downfield (ΔδC +14.4) and upfield (ΔδC  −17.0), respectively, as compared to those of 1, indicative of an alternative conjugation between the diphenyl and diphenylmethane motifs. The planar structure of 3 was finally constructed by 2D NMR spectra (Figures S2 and S22–S24), especially HMBC data. The linkage between two motifs via a C-13−C-4′ bond was confirmed by the key HMBC correlation from H-13 (δH 6.30, s) to C-4′. The substituted patterns in two motifs were assigned to be identical to those of 1 by the HMBC correlations. The tendency of its CD curve (Figure 3) is compatible to that of 1, suggesting that 3 had a 13R-configuration. This was supported by its negative specific rotation as compared to 1.
(+)-Securidane B (4) possessed the same molecular formula C28H24O5 and the identical NMR data as those of 3 (Table S1, Figures S29 and S30), while showing opposite CD curve (Figure 3) and specific rotation of α22D = +42.3 to those of 3. It was thus assigned as the enantiomer of 3 to be 13S-configured.
A direct LC-ESIMS analysis of the fresh ethanolic extract of the plant stems showed the presence of the diagnostic ion peaks at m/z 441 [M + H]+ and 439 [M − H]- for 1−4 (Figure S43), indicating that they are not artifacts produced in the separation.
A possible biosynthetic pathway for 1−4 was proposed (Scheme 1). The co-isolate 5 [9] and a natural product 6 [38] were served as the biosynthetic precursors. Although 6 has not been isolated in this study, it is presumed to exist in the plant either in a low concentration or with a very short lifespan after production. Reduction of 5 by NADPH would produce the key intermediate 7, which was readily transformed to a very stable carbocation 7i. Nucleophilic attack of C-4′ or C-6′ of 6 on to 7i via electrophilic aromatic substitution reaction would produce (−)- and (+)-securidanes A (1 and 2) (route A in pink) and B (3 and 4) (route B in green).
To confirm the biosynthetic hypothesis, we carried out a bioinspired total synthesis of 1−4. The retrosynthetic analysis (Scheme 2) involves a biomimetic assembling of 6a and 7 via Kim’s protocol [25] as the key step to furnish the targeted TAM frameworks of 1−4, in which 7 is the key biosynthetic intermediate, and 6a is the MOM ether of the other biosynthetic precursor 6. Synthesis of fragment 7 in turn was envisioned to arise from aldehyde 10 by a Grignard reaction. While the aldehyde 10 could be made by the treatment of 11 under formylation condition, biaryl compound 6a could be readily prepared from 8 in two steps.
2.1. 　 Synthesis of 7
Compound 11 was prepared in 87% yield by alkylation of 12 [39]. Formylation of 11 then produced two isomeric aldehydes 10 and 10a in a ratio of 2:1 [40, 41]. Addition of Grignard reagents formed from bromobenzene (9) to the aldehyde 10 afforded the desired alcohol 7 in a good yield of 99% (Scheme 3) [42].
2.2. 　 Synthesis of 6a
Biaryl 6a was synthesized from the known starting material 8 (Scheme 4). Enolization of 8 under acidic condition in methanol at room temperature afforded 8a, which was then converted into 6 by refluxing with Hg(OAc)2 in AcOH for 7 h [43]. 6a was finally obtained by protection of the hydroxyl of 6 with MOM ether [44].
2.3. 　 Synthesis of 1−4
With the key fragments 6a and 7 in hand, we next focused on their assembling in the presence of Fe (III) [24] (Scheme 5). The desired coupling products were obtained as a mixture of two racemic pairs 1a−4a, which were dominated by the racemates 3a and 4a (ca. 95%, 1:1) with the minor racemic products 1a and 2a (ca. 5%, 1:1) (determined by HPLC analysis). Deprotection of the MOM ethers [45] afforded a mixture of two pair racemates in 79% total yield, which was further separated into four optically pure compounds 1−4 by chiral HPLC preparation. The products of chemical synthesis were dominated by (−)- and (+)-securidane B (3 and 4, 95%) due largely to the different steric hindrance in two coupling models, while the natural isolates 1−4 from the plant were accounted for approximately 25% each (Figures S3–S6). It is suggested that the transition state in the key step of chemical coupling is different from that of the biosynthesis in the plant, and the MOM ether protection group of chemical synthesis is likely an influencing factor for the ratios of the products.
2.4. 　 PTP1B Inhibitory Evaluation
Compounds 1−4 were tested for the inhibitory effects on PTP1B enzyme by using an in vitro assay [46], and a well-recognized natural PTP1B inhibitor oleanolic acid was used as the positive control (IC50 = 4.14 ± 0.59 μM). Compounds 1−4 showed remarkable inhibition with IC50 values of 15.6 ± 1.37, 12.6 ± 3.68, 7.5 ± 0.74, and 10.5 ± 2.86 μM, respectively. This is the first report of TAMs as PTP1B inhibitors.
2.5. 　 Molecular Docking
The main structural modules furnishing the ligand binding pocket of PTP1B have been demonstrated as the catalytic loop, the YRD motif, and the WPD loop [47]. The molecular docking results (Figures 5, S7, and S8) revealed that the best scoring docking conformations of compounds 1−4 at the binding pocket of PTP1B and their interacting patterns are similar. Taking compound 3 as an example (Figure 5), ring A participates in hydrophobic interactions with Arg47, Asp48, and Val49 at the YRD motif and forms a hydrogen bond with the main-chain of Arg47. Rings C and D bury into a hydrophobic pocket mostly contributed by Try46 at the YRD motif, Phe182 at the WPD loop, and residues at the catalytic site including Ala217, Ile219, and Gly220. Four compounds interact with the same binding pocket, while 3 and 4, a pair of enantiomers, reach deeper into this hydrophobic pocket as compared to 1 and 2. This may contribute to the higher potency of 3 and 4 to PTP1B. The additional hydrogen bond between ring A of 3 and PTP1B, which is devoid in the complex of 4 and PTP1B, makes 3 to be the most potent inhibitor among those four compounds.
3. 　Discussion
Less
In conclusion, we have identified optically pure (−)- and (+)-securidanes A and B (1−4) featuring unprecedented TAM skeletons from a Chinese medicinal plant S. inappendiculata. A plausible biosynthetic pathway for 1−4 based on the coisolated precursor 5 was proposed. Bioinspired total synthesis of 1−4 was achieved in high yield, which in turn corroborated the biosynthetic hypothesis. Compounds 1−4 showed good inhibition against PTP1B. Our efforts provide for the first time the chemophysical data for the optically pure TAM analogues, a bioinspired total synthesis of TAMs, and TAMs as PTP1B inhibitors. This finding is of great importance for understanding the biosynthesis of natural TAMs and exploration of their medicinal potency.
4. 　Materials and Methods
Less
4.1. 　 General Experimental Procedures
The general experiments were completed according to the reported general procedures with minor modification (Experimental Section, Supporting Information) [48].
4.1.1. 　 Plant Material
The detail information of the plant of S. inappendiculata was included in the Experimental Section, Supporting Information.
4.1.2. 　 PTP1B Inhibition Assay
A colorimetric assay for the measurement of PTP1B inhibition was performed according to the reported protocols (Experimental Section, Supporting Information) [46, 49].
4.1.3. 　 Molecular Docking
The crystal structure of PTP1B in complex with one of benzotriazole inhibitors (PDB ID: 1Q6P) was used to prepare the receptor structure, and the centroid of the inhibitor was selected as the center of grid boxes [50]. Water molecules, ions, and the inhibitor were deleted before docking performance. The receptor was then prepared using Protein Preparation and Grid Preparation tools in the Schrödinger Maestro interface. As for ligands, the 3D structures of compounds 1–4 were optimized with B3LYP/6-31G∗ using GAUSSIAN 09 [51, 52]. Molecular docking were performed using the Glide extraprecision mode with default settings [53, 54]. The OPLS-2005 force field was used for minimization and grid generation, while OPLS-2001 was used for docking. Key interactions between compound 3 and PTP1B were analyzed by Ligplot+ [55].
References
Less
1
Nolan E. M., and Lippard S. J., “Tools and tactics for the optical detection of mercuric ion,” Chemical Reviews, vol. 108, no. 9, pp. 3443–3480, 2008
2
Nair V., Thomas S., Mathew S. C., and Abhilash K. G., “Recent advances in the chemistry of triaryl- and triheteroarylmethanes,” Tetrahedron, vol. 62, no. 29, pp. 6731–6747, 2006
3
Miura T., Urano Y., Tanaka K., Nagano T., Ohkubo K., and Fukuzumi S., “Rational design principle for modulating fluorescence properties of fluorescein-based probes by photoinduced electron transfer,” Journal of the American Chemical Society, vol. 125, no. 28, pp. 8666–8671, 2003
4
Muramatsu H., Okumura A., Shibata K., and Matsui M., “Synthesis, absorption spectra, and photostability of triarylmethane dye ethynylogues containing trifluoromethyl group(s),” Chemische Berichte, vol. 127, no. 9, pp. 1627–1632, 1994
5
Duxbury D. F., “The photochemistry and photophysics of triphenylmethane dyes in solid and liquid media,” Chemical Reviews, vol. 93, no. 1, pp. 381–433, 1993
6
Palchaudhuri R., Nesterenko V., and Hergenrother P. J., “The complex role of the triphenylmethyl motif in anticancer compounds,” Journal of the American Chemical Society, vol. 130, no. 31, pp. 10274–10281, 2008
7
Wulff H., and Zhorov B. S., “K+ channel modulators for the treatment of neurological disorders and autoimmune diseases,” Chemical Reviews, vol. 108, no. 5, pp. 1744–1773, 2008
8
Kumar S., Malik V., Kaur N., and Kaur K., “A simple synthesis of di(uracilyl)aryl methanes and 1,ω-bis[di(uracilyl)methyl]benzenes,” Tetrahedron Letters, vol. 47, no. 48, pp. 8483–8487, 2006
9
Mibu N., Yokomizo K., Uyeda M., and Sumoto K., “Synthesis and antiviral activities of some 4,4′- and 2,2′-dihydroxytriphenylmethanes,” Chemical & Pharmaceutical Bulletin, vol. 53, no. 9, pp. 1171–1174, 2005
10
Parai M. K., Panda G., Chaturvedi V., Manju Y. K., and Sinha S., “Thiophene containing triarylmethanes as antitubercular agents,” Bioorganic & Medicinal Chemistry Letters, vol. 18, no. 1, pp. 289–292, 2008
11
Huang Y., and Hayashi T., “Asymmetric synthesis of triarylmethanes by rhodium-catalyzed enantioselective arylation of diarylmethylamines with arylboroxines,” Journal of the American Chemical Society, vol. 137, no. 24, pp. 7556–7559, 2015
12
Nambo M., and Crudden C. M., “Modular synthesis of triarylmethanes through palladium-catalyzed sequential arylation of methyl phenyl sulfone,” Angewandte Chemie International Edition, vol. 53, no. 3, pp. 742–746, 2014, Angew. Chem. 126, 761–765 (2014).
13
Matthew S. C., Glasspoole B. W., Eisenberger P., and Crudden C. M., “Synthesis of enantiomerically enriched triarylmethanes by enantiospecific suzuki-miyaura cross-coupling reactions,” Journal of the American Chemical Society, vol. 136, no. 16, pp. 5828–5831, 2014
14
Matsuo K., Saito S., and Yamaguchi S., “Photodissociation of B-N Lewis adducts: A partially fused trinaphthylborane with dual fluorescence,” Journal of the American Chemical Society, vol. 136, no. 36, pp. 12580–12583, 2014
15
Creutz S. E., and Peters J. C., “Catalytic reduction of N2 to NH3 by an Fe-N 2 complex featuring a C-atom anchor,” Journal of the American Chemical Society, vol. 136, no. 3, pp. 1105–1115, 2014
16
Zhou Q., Srinivas H. D., Dasgupta S., and Watson M. P., “Nickel-catalyzed cross-couplings of benzylic pivalates with arylboroxines: Stereospecific formation of diarylalkanes and triarylmethanes,” Journal of the American Chemical Society, vol. 135, no. 9, pp. 3307–3310, 2013
17
Harris M. R., Hanna L. E., Greene M. A., Moore C. E., and Jarvo E. R., “Retention or inversion in stereospecific nickel-catalyzed cross-coupling of benzylic carbamates with arylboronic esters: Control of absolute stereochemistry with an achiral catalyst,” Journal of the American Chemical Society, vol. 135, no. 9, pp. 3303–3306, 2013
18
Zhang J., Bellomo A., Creamer A. D., Dreher S. D., and Walsh P. J., “Palladium-catalyzed C(sp3)-H arylation of diarylmethanes at room temperature: Synthesis of triarylmethanes via deprotonative-cross-coupling processes,” Journal of the American Chemical Society, vol. 134, no. 33, pp. 13765–13772, 2012
19
Taylor B. L., Harris M. R., and Jarvo E. R., “Synthesis of Enantioenriched Triarylmethanes by Stereospecific Cross-Coupling Reactions,” Angewandte Chemie International Edition, vol. 51, no. 31, pp. 7790–7793, 2012
20
Yuan F.-Q., Gao L.-X., and Han F.-S., “PdCl2-catalyzed efficient allylation and benzylation of heteroarenes under ligand, base/acid, and additive-free conditions,” Chemical Communications, vol. 47, no. 18, pp. 5289–5291, 2011
21
Taylor B. L. H., Swift E. C., Waetzig J. D., and Jarvo E. R., “Stereospecific nickel-catalyzed cross-coupling reactions of alkyl ethers: Enantioselective synthesis of diarylethanes,” Journal of the American Chemical Society, vol. 133, no. 3, pp. 389–391, 2011
22
McGrew G., Temaismithi J., Carroll P., and Walsh P., “Synthesis of Polyarylated methanes through cross-coupling of tricarbonylchromium-activated benzyllithiums,” Angewandte Chemie International Edition, vol. 49, p. 5541, 2010, Angew. Chem. 122, 5673–5676 (2010).
23
Bing Y., Selassie D., Paradise R. H., Isborn C., Kramer N., Sadilek M., Kaminsky W., and Kahr B., “Circular dichroism tensor of a triarylmethyl propeller in sodium chlorate crystals,” Journal of the American Chemical Society, vol. 132, no. 21, pp. 7454–7465, 2010
24
Thirupathi P., and Kim S. S., “Fe(ClO4)3·×H2O-Catalyzed direct C-C bond forming reactions between secondary benzylic alcohols with different types of nucleophiles,” Tetrahedron, vol. 66, no. 16, pp. 2995–3003, 2010
25
Thirupathi P., and Sung S. K., “InBr3: A versatile catalyst for the different types of Friedel-Crafts reactions,” The Journal of Organic Chemistry, vol. 74, no. 20, pp. 7755–7761, 2009
26
Dibwe D. F., Awale S., Kadota S., Morita H., and Tezuka Y., “Muchimangins G-J, fully substituted xanthones with a diphenylmethyl substituent, from securidaca longepedunculata,” Journal of Natural Products, vol. 77, no. 5, pp. 1241–1244, 2014
27
Dibwe D. F., Awale S., Kadota S., Morita H., and Tezuka Y., “Muchimangins e and F: Novel diphenylmethyl-substituted xanthones from Securidaca longepedunculata,” Tetrahedron Letters, vol. 55, no. 11, pp. 1916–1919, 2014
28
Jin C., Michetich R. G., and Daneshtalab M., “Flavonoids from Stellera chamaejasme,” Phytochemistry, vol. 50, no. 3, pp. 505–508, 1998
29
Seligmann O., and Wagner H., “Structure determination of melanervin, the first naturally occurring flavonoid of the triphenylmethane family,” Tetrahedron, vol. 37, no. 15, pp. 2601–2606, 1981
30
Chen S. K., Chen B. Y., and Li H. In Zhongguo Zhiwu Zhi, Science Press, Beijing, vol. 43, 1997
31
Zuo J., Mao K.-J., Yuan F., Li X., and Chen J.-W., “Xanthones with anti-tumor activity isolated from Securidaca inappendiculata,” Medicinal Chemistry Research, vol. 23, no. 11, pp. 4865–4871, 2014
32
Zhang L., Yang X., Xu L., and Yang S., “Three New Xanthones from the Roots of Securidaca inappendiculata,” Heterocycles, vol. 65, no. 7, p. 1685, 2005
33
Kang W., Ji Z., and Wang J., “A new xanthone from the roots of Securidaca inappendiculata,” Chemical Papers, vol. 63, no. 1, 2009
34
Yang X.-D., Xu L.-Z., and Yang S.-L., “Xanthones from the stems of Securidaca inappendiculata,” Phytochemistry, vol. 58, no. 8, pp. 1245–1249, 2001
35
Haftchenary S., Jouk A. O., Aubry I., Lewis A. M., Landry M., Ball D. P., Shouksmith A. E., Collins C. V., Tremblay M. L., and Gunning P. T., “Identification of bidentate salicylic acid inhibitors of PTP1B,” ACS Medicinal Chemistry Letters, vol. 6, no. 9, pp. 982–986, 2015
36
Comeau A. B., Critton D. A., Page R., and Seto C. T., “A focused library of protein tyrosine phosphatase inhibitors,” Journal of Medicinal Chemistry, vol. 53, no. 18, pp. 6768–6772, 2010
37
Marx J., “Unraveling the causes of diabetes,” Science, vol. 296, no. 5568, pp. 686–689, 2002
38
Song M.-C., Nigussie F., Jeong T.-S., Lee C.-Y., Regassa F., Markos T., and Baek N.-I., “Phenolic compounds from the roots of Lindera fruticosa,” Journal of Natural Products, vol. 69, no. 5, pp. 853–855, 2006
39
McKittrick B. A., and Stevenson R., “Synthesis of the yeast antioxidant benzofuran and analogues,” Journal of the Chemical Society, Perkin Transactions 1, pp. 709–712, 1984
40
Benington F., and Morin R. D., “Contribution to the Structure of Falcatine. Synthesis of Isoanhydrofalcatine Lactam,” The Journal of Organic Chemistry, vol. 27, no. 1, pp. 142–146, 1962
41
Wagner A. F., Walton E., Wilson A. N., Rodin J. O., Holly F. W., Brink N. G., and Folkers K., “Synthesis of Degradation Products of 2-(6-Hydroxy-2-methoxy-3, 4-methylenedioxyphenyl)-benzofuran,” Journal of the American Chemical Society, vol. 81, no. 18, pp. 4983–4989, 1959
42
Tabuchi S., Hirano K., Satoh T., and Miura M., “Synthesis of triarylmethanes by palladium-catalyzed c-h/c-o coupling of oxazoles and diarylmethanol derivatives,” The Journal of Organic Chemistry, vol. 79, no. 12, pp. 5401–5411, 2014
43
Lebeuf R., Robert F., and Landais Y., “Regioselectivity of birch reductive alkylation of biaryls,” Organic Letters, vol. 7, no. 21, pp. 4557–4560, 2005
44
Castello L. M., Hornillos V., Vila C., Giannerini M., Fananas-Mastral M., and Feringa B. L., “Pd-Catalyzed Cross-Coupling of Aryllithium Reagents with 2-Alkoxy-Substituted Aryl Chlorides: Mild and Efficient Synthesis of 3, 3′-Diaryl BINOLs,” Organic Letters, vol. 17, pp. 62–65, 2014
45
Ramesh C., Ravindranath N., and Das B., “Simple, efficient, and selective deprotection of phenolic methoxymethyl ethers using silica-supported sodium hydrogen sulfate as a heterogeneous catalyst,” The Journal of Organic Chemistry, vol. 68, no. 18, pp. 7101–7103, 2003
46
Zhang W., Hong D., Zhou Y., Zhang Y., Shen Q., Li J.-Y., and Hu L.-H., “Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1760, no. 10, pp. 1505–1512, 2006
47
Johnson T. O., Ermolieff J., and Jirousek M. R., “Protein tyrosine phosphatase 1B inhibitors for diabetes,” Nature Reviews Drug Discovery, vol. 1, no. 9, pp. 696–709, 2002
48
Zhou B., Shen Y., Wu Y., Leng Y., and Yue J.-M., “Limonoids with 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitory Activities from Dysoxylum mollissimum,” Journal of Natural Products, vol. 78, no. 8, pp. 2116–2122, 2015
49
Yu J.-H., Liu Q.-F., Sheng L., Wang G.-C., Li J., and Yue J.-M., “Cipacinoids A-D, four limonoids with spirocyclic skeletons from cipadessa cinerascens,” Organic Letters, vol. 18, no. 3, pp. 444–447, 2016
50
Scapin G., Patel S. B., Becker J. W., Wang Q., Desponts C., Waddleton D., Skorey K., Cromlish W., Bayly C., Therien M., Gauthier J. Y., Li C. S., Lau C. K., Ramachandran C., Kennedy B. P., and Asante-Appiah E., “The structural basis for the selectivity of benzotriazole inhibitors of PTP1B,” Biochemistry, vol. 42, no. 39, pp. 11451–11459, 2003
51
Frisch M., Trucks G., Schlegel H. B., Scuseria G., Robb M., Cheeseman J., Scalmani G., Barone V., Mennucci B., and Petersson G., “Gaussian 09, Revision A. 02, Gaussian. Inc., Wallingford, CT,” , 2009, 200.
52
Becke A. D., “Density-functional thermochemistry. III. The role of exact exchange,” The Journal of Chemical Physics, vol. 98, no. 7, pp. 5648–5652, 1993
53
Friesner R. A., Murphy R. B., Repasky M. P., Frye L. L., Greenwood J. R., Halgren T. A., Sanschagrin P. C., and Mainz D. T., “Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes,” Journal of Medicinal Chemistry, vol. 49, no. 21, pp. 6177–6196, 2006
54
Friesner R. A., Banks J. L., Murphy R. B., Halgren T. A., Klicic J. J., Mainz D. T., Repasky M. P., Knoll E. H., Shelley M., Perry J. K., Shaw D. E., Francis P., and Shenkin P. S., “Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy,” Journal of Medicinal Chemistry, vol. 47, no. 7, pp. 1739–1749, 2004
55
Laskowski R. A., and Swindells M. B., “LigPlot+: multiple ligand-protein interaction diagrams for drug discovery,” Journal of Chemical Information and Modeling, vol. 51, no. 10, pp. 2778–2786, 2011
Appendix
Less
Year 2018 volume 2018 Issue 9
PDF
78
41
Cite this Article
BibTeX
Article Info
doi: 10.1155/2018/2674182
  • Receive Date：2018-05-23
  • Online Date：2026-10-27
  • Published：2018-09-20
Article Data
Affiliations
History
  • Received：2018-05-23
  • Accepted：2018-08-10
Affiliations
    1State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China
    2State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China
References
Share
https://castjournals.cast.org.cn/joweb/research/EN/10.1155/2018/2674182
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House